Caffeine, theophylline and theobromine are the most known methylxanthines as they are present in coffee, tea and/or chocolate. In the last decades, a huge experimental effort has been devoted to get insight into the variety of actions that these compounds exert in humans. From such knowledge it is known that methylxanthines have a great potential in prevention, therapy and/or management of a variety of diseases. The benefits of methylxanthine-based therapies in the apnea of prematurity and their translational potential in pediatric affections of the respiratory tract are here presented.
Keywords: Airways; Apnea of prematurity; Asthma; Caffeine; Cough; Theobromine; Theophylline; Xanthine.
Copyright © 2016 Elsevier Ltd. All rights reserved.